- more recent presentations may be available upon request
Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity click here >>
AlphaVax’s Vector System Shows Potential for Cancer Immunotherapy click here >>
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers click here >>
Alphavirus Replicon Vaccines for Marburg and Ebola Viruses click here >>
5/8/2009
Flow-Cytometric Evaluation of T Cell Responses Elicited by an Alphavirus Replicon Particle Vaccine for Cytomegalovirus (CMV) in Healthy Adults The American Association of Immunologists Meeting, Seattle, WA click here >>
Alphavirus Replicon Particles Expressing Melanocyte Differentiation Antigens are Effective Vaccines for Melanoma The American Association of Immunologists Meeting, Seattle, WA click here >>
Use of Alphavirus Replicons Expressing IL-12 as Highly Potent Vaccine Adjuvants 2nd Global Vaccine Congress Meeting, Boston, MA click here >>
Safety and Immunogenicity of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV) ICAAC/IDSA Meeting, Washington, DC click here >>
Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus click here >>
Evaluation of Cellular Immune Responses Induced in Mice by Alphavirus Replicon Particle Vaccines for SARS-CoV The American Association of Immunologists Meeting, Miami, FL click here >>
Immunogenicity of an Alphavirus Replicon Particle Vaccine Expressing SARS-CoV Spike (S) Glycoprotein in Non-human Primates The American Association of Immunologists Meeting, Miami, FL click here >>
The Effect of Different Glycoprotein Coats on Alphavirus-Replicon Particle Immunogenicity Positive Strand RNA Viruses Meeting, Washington, DC click here >>
Cellular and Humoral Immune Responses to Alphavirus Replicon Vaccines Expressing Cytomegalovirus pp65, IE1, and gB Proteins click here >>
Vaccines Redefined